Experience of participating in safety knowledge competition
Release time:
2020-08-14
Experience of Participating in Safety Knowledge Contest
6# May 26 , the safety knowledge contest of 2018 "Safety Production Month" hosted by the Safety Management Office of Zhejiang Jianfeng Group Co., Ltd. came to a successful conclusion. The three of us are honored to be able to participate in this event, which is not only a test for us, so that we have a deeper understanding of corporate security, at the same time, the importance of safety education also has a closer understanding. In line with the attitude of learning to participate in this competition, although some mistakes, but also gained a lot.
A month ago, we received the task of the competition. In addition to the knowledge accumulation of daily safety and environmental protection management, we also focused on the "the People's Republic of China Safety Production Law", "the People's Republic of China Occupational Disease Prevention Law", "Production Safety Accident Work Injury Insurance Regulations" and other laws and regulations before the competition. The "Safety Education Reader" and safety knowledge exercises issued by the group company were the main contents for preparation.
Through this competition, we also clearly recognize the lack of our own business level, the gap with other brother units, and know where our weakness lies. We learn from experience and lessons, sum up experience from success, strengthen the improvement of our own business level, and pay attention to the accumulation of ordinary times. "Don't be afraid of ten thousand, just be afraid of one thousand", although it is a common saying, it contains profound philosophy. It is not only applicable to life, but also suitable for being angry and enterprising. It is of great significance in safe production. Ten thousand times is not terrible, the fear is that there is one in ten thousand. Even if it is negligent, even if it is in violation of regulations and discipline, it can make 9,999 times of hard work and all previous efforts come to naught. It will make the wish of a safe life come to naught and leave you.
Participating in this activity made me once again deeply realize that on the issue of safety, there must be no paralysis or luck. We must take precautions first, be vigilant first, be alert to thinking, be in line with regulations and be cautious in action. We must establish a high degree of safety awareness. Everyone talks about safety, always talks about safety, and everything talks about safety; it is necessary to build a great wall of safety in thought, behavior and life to escort the company's safe production.
Although this competition has come to an end, we must firmly remember that "safe production work is always on the road, there is only a starting point, no end point, and can only be strengthened and not relaxed at any time" to ensure safe production. Eternal theme. (Liu Fengbin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page